Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Phase II INTEGRIS-PSC trial of bexotegrast, an αvβ6/αvβ1 integrin inhibitor, in primary sclerosing cholangitis

作者:Gideon M. Hirschfield, Kris V. Kowdley, Palak Trivedi, Bertus Eksteen, Bilal Hameed, Catherine Vincent, Tianyan Chen, Aparna Goel, K. Gautham Reddy, Eric S. Orman, Deepak Joshi, Éric Lefebvre, Johanna Schaub, Mahru C. An, Annie Clark, Chris N. Barnes, Richard Pencek, Douglas Thorburn, Aldo J. Montaño‐Loza, Christoph Schramm, Christopher L. Bowlus, Michael Trauner, Cynthia Levy · 发表于:Journal of Hepatology · 年份:2025 · DOI:10.1016/j.jhep.2025.09.016 · 被引用次数:8 · 研究领域:Liver Diseases and Immunity、Inflammatory Bowel Disease、Rheumatoid Arthritis Research and Therapies